SCHEMBL1180957

SCHEMBL1180957

Brc1[c]nccc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9099559 0.76
SCHEMBL4607074 0.74
SCHEMBL3432940 0.74
SCHEMBL1180970 0.74
SCHEMBL1180079 0.74
SCHEMBL1180081 0.74
SCHEMBL3432939 0.74
SCHEMBL3431780 0.69
SCHEMBL16703165 0.69
SCHEMBL317518 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112592335-A Carbazole isopropanol diamine compound containing 1, 2, 3-triazole and preparation method and application thereof 贵州大学 2021-04-02 CN claimed
US-8148537-B2 Substituted acetophenones useful as PDE4 inhibitors LEO PHARMA A/S (DK) 2012-04-03 US claimed
CN-112624962-B Carbazolyl isopropanolamine derivatives with double chiral centers and preparation method and application thereof 贵州大学 2023-03-31 CN disclosed
US-20220160908-A1 CHELATORS AND METHODS OF MAKING AND USING SAME PROVINCIAL HEALTH SERVICES AUTHORITY (CA) 2022-05-26 US disclosed
CN-112592335-A Carbazole isopropanol diamine compound containing 1, 2, 3-triazole and preparation method and application thereof 贵州大学 2021-04-02 CN disclosed
WO-2020186328-A1 CHELATORS AND METHODS OF MAKING AND USING SAME THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2020-09-24 WO disclosed
US-20130045993-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES AND THEIR USE Piramal Enterprises Limited (IN) 2013-02-21 US disclosed
US-8304449-B2 Inhibitors of cyclin dependent kinases and their use PIRAMAL HEALTHCARE LIMITED (IN) 2012-11-06 US disclosed
US-20110136873-A1 Inhibitors of Cyclin Dependent Kinases and Their Use PIRAMAL LIFE SCIENCES LTD. (IN) 2011-06-09 US disclosed
US-7915301-B2 chromenone derivatives of nitrogen-, oxygen- or sulfur-containing saturated heterocycles; preparation by cyclizing benzoyl intermediates; antiproliferative agents; 2-(2-Chloro-phenyl)-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-5,7-dimethoxy-chromen-4-one Piramal Life Science Limited (IN) 2011-03-29 US disclosed
US-7884127-B2 chromenone derivatives of nitrogen-, oxygen- or sulfur-containing saturated heterocycles; preparation by cyclizing benzoyl intermediates; antiproliferative agents; 2-(2-Chloro-phenyl)-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-5,7-dimethoxy-chromen-4-one; acidification Pirimal Life Sciences Ltd. (IN) 2011-02-08 US disclosed
WO-2004004632-A2 FLAVONE DERIVATIVES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES NICHOLAS PIRAMAL INDIA LIMITED (IN) 2004-01-15 WO disclosed
EP-1341766-A1 IMIDAZOLONE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2003-09-10 EP disclosed
US-20030069276-A1 Amino piperidine derivatives F.HOFFMANN-LA ROCHE AG (CH) 2003-04-10 US disclosed
US-6538015-B1 Process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds of formula I are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is HOFFMANN-LA ROCHE INC. 2003-03-25 US disclosed
US-6518293-B2 Inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is involved in viral replication. HOFFMANN-LA ROCHE INC. 2003-02-11 US disclosed
WO-2002100853-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-12-19 WO disclosed
WO-2002079186-A2 AMINOPIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2002-10-10 WO disclosed
US-20020107272-A1 Anti-HIV imidazolone derivatives F. HOFFMANN-LA ROCHE AG (CH) 2002-08-08 US disclosed
WO-2002042279-A1 IMIDAZOLONE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2002-05-30 WO disclosed